BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24259647)

  • 21. Expanding professional pharmacy services in European community setting: Is it cost-effective? A systematic review for health policy considerations.
    Perraudin C; Bugnon O; Pelletier-Fleury N
    Health Policy; 2016 Dec; 120(12):1350-1362. PubMed ID: 28228230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Déjà vu all over again? Medication use and pharmacists' reimbursement in an era of reform.
    Shinogle JA
    Clin Ther; 2011 Dec; 33(12):2004-5. PubMed ID: 22177373
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical pharmacists as key members of the patient-centered medical home: an opinion statement of the Ambulatory Care Practice and Research Network of the American College of Clinical Pharmacy.
    Nigro SC; Garwood CL; Berlie H; Irons B; Longyhore D; McFarland MS; Saseen JJ; Trewet CB
    Pharmacotherapy; 2014 Jan; 34(1):96-108. PubMed ID: 24122857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving care transitions: current practice and future opportunities for pharmacists.
    ; Hume AL; Kirwin J; Bieber HL; Couchenour RL; Hall DL; Kennedy AK; LaPointe NM; Burkhardt CD; Schilli K; Seaton T; Trujillo J; Wiggins B
    Pharmacotherapy; 2012 Nov; 32(11):e326-37. PubMed ID: 23108810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of pharmacist contributions to diabetes care in the United States.
    Armor BL; Britton ML; Dennis VC; Letassy NA
    J Pharm Pract; 2010 Jun; 23(3):250-64. PubMed ID: 21507822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Redefining the role of the pharmacist: medication therapy management.
    Hilsenrath P; Woelfel J; Shek A; Ordanza K
    J Rural Health; 2012; 28(4):425-30. PubMed ID: 23083089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacists belong in accountable care organizations and integrated care teams.
    Smith M; Bates DW; Bodenheimer TS
    Health Aff (Millwood); 2013 Nov; 32(11):1963-70. PubMed ID: 24191087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A patient-centered pharmacy services model of HIV patient care in community pharmacy settings: a theoretical and empirical framework.
    Kibicho J; Owczarzak J
    AIDS Patient Care STDS; 2012 Jan; 26(1):20-8. PubMed ID: 22149903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing resident physician use of clinical pharmacy services.
    Lounsbery JL; Moon J; Humphrey A; Prasad S
    Fam Med; 2013 Jan; 45(1):33-6. PubMed ID: 23334965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Agreement between pharmacists for problem identification: an initial quality measurement of cognitive services.
    LaFleur J; Larson BS; Gunning KM; Stoddard GJ; Madden C; Oderda L; Steinvoort C; Oderda GM
    Ann Pharmacother; 2009 Jul; 43(7):1173-80. PubMed ID: 19584393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Individual medication management system (IMMS) implementation in pharmacists' opinion.
    Waszyk-Nowaczyk M; Lawicki S; Michalak M; Simon M
    Acta Pol Pharm; 2014; 71(3):509-14. PubMed ID: 25265831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reimbursement model for pharmacist-directed medication therapy management.
    Lloyd KB; Evans RL
    J Am Pharm Assoc (2003); 2012; 52(2):161-9. PubMed ID: 22370378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimating the cost of the Medicare Pharmacist Services Coverage Act of 2001.
    Poole VH; Moran DW; Webb CE
    Pharmacotherapy; 2003 Aug; 23(8):955-65. PubMed ID: 12921241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic evaluation of pharmacist-led medication reviews in residential aged care facilities.
    Hasan SS; Thiruchelvam K; Kow CS; Ghori MU; Babar ZU
    Expert Rev Pharmacoecon Outcomes Res; 2017 Oct; 17(5):431-439. PubMed ID: 28825502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Economic outcomes and contemporary pharmacy practice.
    Reeder CE
    Am Pharm; 1993 Dec; NS33(12 Suppl):S3-6. PubMed ID: 8109541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Process indicators of quality clinical pharmacy services during transitions of care.
    ; Kirwin J; Canales AE; Bentley ML; Bungay K; Chan T; Dobson E; Holder RM; Johnson D; Lilliston A; Mohammad RA; Spinler SA
    Pharmacotherapy; 2012 Nov; 32(11):e338-47. PubMed ID: 23108762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting suboptimal prescribing in the elderly: a review of the impact of pharmacy services.
    Castelino RL; Bajorek BV; Chen TF
    Ann Pharmacother; 2009 Jun; 43(6):1096-106. PubMed ID: 19470856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacists' acceptable levels of compensation for MTM services: a conjoint analysis.
    Wang J; Hong SH; Meng S; Brown LM
    Res Social Adm Pharm; 2011 Dec; 7(4):383-95. PubMed ID: 21272533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Collaborative prescribing: a qualitative exploration of a role for pharmacists in mental health.
    Wheeler A; Crump K; Lee M; Li L; Patel A; Yang R; Zhao J; Jensen M
    Res Social Adm Pharm; 2012; 8(3):179-92. PubMed ID: 21831724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmaceutical care, MTM, & payment: the past, present, & future.
    Isetts BJ
    Ann Pharmacother; 2012 Apr; 46(4):S47-56. PubMed ID: 22499741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.